JohnKCamorianoDO
Oncology • Scottsdale, AZAssistant Professor, Internal Medicine, Mayo Medical School
Dr. Camoriano is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
13400 E Shea Blvd
Scottsdale, AZ 85259Phone+1 480-301-8000
Education & Training
University of New England College of Osteopathic MedicineClass of 2011
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1985 - 1988
University of Oklahoma Health Sciences CenterResidency, Internal Medicine, 1982 - 1985
Certifications & Licensure
AZ State License 1989 - 2025
MN State License 1985 - 2001
OK State License 1983 - 1985- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2008-2014
- Top Doctors:Arizona State Castle Connolly, 2013
- America's Top Doctors for Cancer Castle Connolly, 2007-2013
Clinical Trials
- Lapatinib and Topotecan in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Did Not Respond to Cisplatin or Carboplatin Start of enrollment: 2007 Mar 01
- Ribociclib and Letrozole in Treating Patients With Relapsed ER Positive Ovarian, Fallopian Tube, Primary Peritoneal, or Endometrial Cancer Start of enrollment: 2016 Jul 08
Publications & Presentations
PubMed
- 44 citationsPhase II trial of ribociclib and letrozole in patients with relapsed oestrogen receptor-positive ovarian or endometrial cancersGerardo Colon-Otero, Valentina Zanfagnin, Xiaonan Hou, Nathan R. Foster, Erik Asmus
ESMO Open. 2020-10-01 - 258 citationsInternational Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatm...Ayalew Tefferi, Giovanni Barosi, Ruben A. Mesa, Francisco Cervantes, H. Joachim Deeg
Blood. 2006-09-01 - 210 citationsWeight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer.John K. Camoriano, Charles L. Loprinzi, James N. Ingle, Terry M. Therneau, James E. Krook
Journal of Clinical Oncology. 1990-08-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
